Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. John Stewart Horton
WARNING LETTER
•John Stewart Horton•September 6, 2012

John Stewart Horton – FDA Warning Letter, Sep 6, 2012

Record Details

The FDA conducted an investigation of John Stewart Horton's dairy operation on August 20 and September 6, 2012, identifying multiple violations of the Federal Food, Drug, and Cosmetic Act. The primary finding was the sale of five bob veal calves for slaughter as food that were adulterated, containing illegal residues of neomycin in their kidney tissues, exceeding the established tolerance of 7.2 ppm (21 C.F.R. 556.430(b)(1)). This constitutes adulterated food under section 402(a)(2)(C)(ii) of the FD&C Act. Further, the investigation revealed that animals were held under inadequate conditions, making it likely that medicated animals with harmful drug residues could enter the food supply, thus adulterating food under section 402(a)(4). Specific deficiencies included failure to maintain treatment records and properly identify bob veal calves for sale. The firm also adulterated the new animal drug (b)(4) (neomycin sulfate and oxytetracycline hydrochloride) through extralabel use, specifically by administering it in or on feed (21 C.F.R. 530.11(b)) and causing illegal drug residues (21 C.F.R. 530.11(c)). This extralabel use, not in conformance with approved labeling, rendered the drug unsafe and adulterated under section 501(a)(5). Additionally, (b)(4) medicated feed was adulterated under section 501(a)(6) due to its use not conforming to approved labeling, making it unsafe under section 512. Mr. Horton is responsible for ensuring compliance and must take prompt corrective action. A written response detailing steps taken to correct violations and prevent recurrence is required within fifteen working days, with potential regulatory actions like seizure or injunction for non-compliance.

Company
John Stewart Horton
Inspection date
September 6, 2012
Product type
Drugs
Office
New York District Office
People
  • David H. Smith
  • Dean Rugnetta
  • Ronald M. Pace (Program Director)
View Company Profile

ID · 518efa9d-832a-4ce6-8876-39d72bb59f31

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 53021 CFR 530.11(b)21 CFR 530.11(c)21 U.S.C. 360b(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore John Stewart Horton
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.